Funds research to develop advanced, user-friendly point-of-care diagnostic devices for rapid, accurate patient testing, with clinical validation and a focus on resource-limited settings and digital technologies.
Funder: European Commission
Due Dates: April 13, 2027 (first-stage) | September 22, 2027 (second-stage)
Funding Amounts: €5–7 million per project; ~6 projects funded; lump sum; project duration typically 3–5 years
Summary: Supports the development of advanced, user-friendly point-of-care diagnostic devices to accelerate clinical decision-making and improve patient outcomes, especially in resource-limited settings.
Key Information: Two-stage, blind evaluation; clinical validation and regulatory alignment required; proposals must address technical, clinical, and value-based criteria.
This Horizon Europe Innovation Action funds research and development of portable, versatile point-of-care (PoC) diagnostic devices that enable rapid, accurate, and user-friendly testing at the site of patient care. The call focuses on addressing technical challenges—such as sensitivity, specificity, ease of use, miniaturization, biocompatibility, mass production, high-throughput readiness, and environmental sustainability—while ensuring clinical relevance and regulatory compliance. Proposals should be driven by a clear clinical need, integrate value-based and health technology assessment concepts, and include comparative studies and clinical validation in line with EU regulatory requirements (IVDR/MDR). Solutions suitable for resource-limited settings and leveraging digital/mobile technologies, including AI-powered analysis, are particularly encouraged.
Expected outcomes include: